Field calibration of PADC track etch detectors for local neutron dosimetry in man using different radiation qualities

[1]  K. Shin,et al.  Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy. , 2010, International journal of radiation oncology, biology, physics.

[2]  Anatoly Rosenfeld,et al.  Assessment of out-of-field absorbed dose and equivalent dose in proton fields. , 2009, Medical physics.

[3]  D. Followill,et al.  Secondary neutron spectra from modern Varian, Siemens, and Elekta linacs with multileaf collimators. , 2009, Medical physics.

[4]  D. Followill,et al.  Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  Vlachoudis.  FLAIR: A POWERFUL BUT USER FRIENDLY GRAPHICAL INTERFACE FOR FLUKA , 2009 .

[6]  Harald Paganetti,et al.  A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction , 2008, Physics in medicine and biology.

[7]  D. Followill,et al.  A Monte Carlo model for out-of-field dose calculation from high-energy photon therapy. , 2007, Medical physics.

[8]  Anatoly Rosenfeld,et al.  Out-of-field dose equivalents delivered by proton therapy of prostate cancer. , 2007, Medical physics.

[9]  F. Cerutti,et al.  The FLUKA code: Description and benchmarking , 2007 .

[10]  D. Low.  Image-Guided IMRT. , 2006, Medical physics.

[11]  L. Myrianthopoulos,et al.  In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18MV IMRT. , 2006, Medical physics.

[12]  M. Tadokoro,et al.  Measurement of neutron dose distribution for a passive scattering nozzle at the Proton Medical Research Center (PMRC) , 2006 .

[13]  R. Stewart,et al.  Neutron scattered dose equivalent to a fetus from proton radiotherapy of the mother. , 2006, Medical physics.

[14]  Gary D Fullerton,et al.  Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies. , 2006, Medical physics.

[15]  A. Ferrari,et al.  FLUKA: A Multi-Particle Transport Code , 2005 .

[16]  David S Followill,et al.  Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy. , 2005, International journal of radiation oncology, biology, physics.

[17]  S. Roy,et al.  Scattered neutron dose equivalent to a fetus from proton therapy of the mother , 2004 .

[18]  A. Kellerer.  Weighting factors for radiation quality: how to unite the two current concepts. , 2004, Radiation protection dosimetry.

[19]  D Huyskens,et al.  Peripheral neutron and gamma doses in radiotherapy with an 18 MV linear accelerator. , 2004, Radiation protection dosimetry.

[20]  H. Schuhmacher.  Neutron calibration facilities. , 2004, Radiation protection dosimetry.

[21]  V. Mareš,et al.  Options for the modified radiation weighting factor of neutrons. , 2004, Radiation protection dosimetry.

[22]  D. Followill,et al.  Neutron source strength measurements for Varian, Siemens, Elekta, and General Electric linear accelerators , 2003, Journal of applied clinical medical physics.

[23]  E. Pedroni,et al.  Secondary neutron dose during proton therapy using spot scanning. , 2002, International journal of radiation oncology, biology, physics.

[24]  A. Koehler,et al.  Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field , 2002 .

[25]  C. Wernli,et al.  Individual Neutron Monitoring with CR-39 Detectors at an Accelerator Centre , 1999 .

[26]  J. H. Hough,et al.  Secondary Dose Exposures During 200 MeV Proton Therapy , 1997 .